Myocardial Infarction (Heart Attack)

content of this page

1- Introduction

2- Anatomical Overview

3- Causes

4- Treatment 


Myocardial infarction, commonly known as a heart attack, is a serious medical emergency that occurs when there is a sudden interruption of blood flow to a part of the heart muscle, leading to damage or death of heart tissue. This interruption typically results from the blockage of one or more coronary arteries, which supply oxygen-rich blood to the heart. Myocardial infarction is a leading cause of death worldwide and requires prompt medical attention to minimize damage and prevent complications.
© image from moore clinically oriented anatomy

Anatomical Overview

With sudden occlusion of a major artery by an embolus (G. embolos, plug), the region of myocardium supplied by the occluded vessel becomes infarcted (rendered virtually bloodless) and undergoes necrosis (pathological tissue death). The three most common sites of coronary artery occlusion and the percentage of occlusions involving each artery are the:                                                                                                     1. Anterior IV (LAD) branch of the LCA (40–50%).                                                                                             2. RCA (30–40%).
 3. Circumflex branch of the LCA (15–20%).

© image from moore clinically oriented anatomy


  • Coronary Artery Disease (CAD):

    • Atherosclerosis: The most common cause of myocardial infarction is the buildup of atherosclerotic plaques within the coronary arteries. These plaques consist of cholesterol, fatty deposits, cellular debris, and inflammatory cells that narrow the artery lumen, reducing blood flow to the heart muscle.
    • Plaque Rupture: Rupture or erosion of an atherosclerotic plaque can lead to the formation of blood clots (thrombi) that obstruct coronary blood flow, causing acute myocardial infarction.
  • Risk Factors:

    • Hypertension (high blood pressure)
    • Hyperlipidemia (elevated levels of cholesterol and triglycerides)
    • Diabetes mellitus
    • Smoking
    • Obesity
    • Sedentary lifestyle
    • Family history of premature coronary artery disease
    • Age (risk increases with advancing age)
  • Other Causes:

    • Coronary Artery Spasm: Spasm of the coronary arteries, often triggered by emotional stress, cold exposure, or certain medications, can cause temporary constriction and reduce blood flow, leading to myocardial ischemia and infarction.
    • Coronary Embolism: Embolism, the blockage of a coronary artery by a blood clot or other material originating from a distant site (e.g., the heart or a blood vessel), can cause myocardial infarction.
    • Coronary Artery Dissection: Dissection, or tearing of the coronary artery wall, can obstruct blood flow and cause myocardial infarction, particularly in individuals with connective tissue disorders or following trauma.
  • Non-atherosclerotic Causes:

    • Coronary Artery Spontaneous Dissection (SCAD): Spontaneous dissection of the coronary arteries, often occurring in young individuals, particularly women, without significant atherosclerosis, can lead to myocardial infarction.
    • Coronary Artery Vasculitis: Inflammatory conditions affecting the coronary arteries, such as Kawasaki disease, Takayasu arteritis, or autoimmune disorders, can cause vessel inflammation, stenosis, or occlusion, leading to myocardial infarction.


  • Immediate Medical Care:

    • Call Emergency Services: If you suspect a heart attack, call emergency services immediately or seek medical assistance without delay.
    • Administer Aspirin: Chewing or swallowing aspirin (unless contraindicated) can help prevent blood clot formation and reduce the risk of further clotting.
    • Oxygen Therapy: Supplemental oxygen may be administered to improve oxygenation and alleviate symptoms of hypoxemia.
  • Reperfusion Therapy:

    • Percutaneous Coronary Intervention (PCI): PCI, also known as coronary angioplasty, involves the insertion of a catheter with a balloon tip into the blocked coronary artery to widen the narrowed segment and restore blood flow. Often, a stent is placed to keep the artery open.
    • Thrombolytic Therapy: Thrombolytic drugs (clot-busting medications) may be administered intravenously to dissolve blood clots and restore blood flow in cases where PCI is not immediately available or feasible.
  • Medications:

    • Antiplatelet Agents: Drugs such as aspirin, clopidogrel, or ticagrelor inhibit platelet aggregation and help prevent further clot formation.
    • Anticoagulants: Medications like heparin or low molecular weight heparin (LMWH) may be used to prevent blood clot formation and reduce the risk of thrombosis.
    • Beta-Blockers: Beta-blockers, such as metoprolol or carvedilol, reduce heart rate, blood pressure, and myocardial oxygen demand, thereby protecting the heart muscle and reducing the risk of arrhythmias.
    • Nitroglycerin: Nitroglycerin is used to relieve chest pain (angina) and improve blood flow to the heart by dilating coronary arteries.
    • Statins: Statin medications, such as atorvastatin or simvastatin, lower cholesterol levels and reduce the risk of recurrent cardiovascular events.
    • Angiotensin-Converting Enzyme (ACE) Inhibitors or Angiotensin Receptor Blockers (ARBs): These medications help improve cardiac function, prevent remodeling of the heart, and reduce the risk of heart failure.
  • Cardiac Rehabilitation:

    • Following acute treatment, participation in a cardiac rehabilitation program is recommended to optimize recovery, improve cardiovascular fitness, and reduce the risk of future cardiovascular events.
  • Secondary Prevention:

    • Lifestyle Modifications: Adopting a heart-healthy lifestyle, including regular exercise, healthy diet choices, smoking cessation, weight management, and stress reduction, is crucial for preventing recurrent myocardial infarction and managing cardiovascular risk factors.
    • Regular Medical Follow-Up: Regular monitoring by healthcare providers is essential for ongoing management of cardiovascular risk factors, medication optimization, and long-term prevention of recurrent events.
Scroll to Top